Your greatest defense is within you. Immunocine was founded to bring revolutionary immunotherapy to cancer patients who are not eligible for FDA clinical trials. Our proprietary treatment, Immunocine Dendritic Cell Therapy (IDCT), “double loads” a patient’s dendritic cells with their own cancer cells. This process mimics a viral infection and triggers a powerful, targeted immune response. Backed by 16 years of research and ongoing FDA trials, IDCT offers a less invasive, highly precise option for treating multiple types of cancer. Visit our website to see if you’re eligible to apply for treatment.
Shared 1 month ago
130K views
Shared 2 months ago
11K views
Shared 2 months ago
201 views
Shared 6 months ago
507 views
Shared 7 months ago
383 views
Shared 8 months ago
1.4K views
Shared 9 months ago
413 views
Shared 11 months ago
2K views
Shared 1 year ago
8.9K views
Shared 1 year ago
709 views
Shared 1 year ago
843 views
Shared 1 year ago
1.3K views
Shared 1 year ago
1.3K views
Shared 1 year ago
1.4K views
Shared 1 year ago
4.3K views
Shared 1 year ago
3.1K views
Shared 1 year ago
891 views
Shared 1 year ago
1.9K views
Shared 1 year ago
397 views
Shared 1 year ago
445 views
Shared 1 year ago
756 views
Shared 2 years ago
7.5K views
Shared 2 years ago
3.8K views
Shared 2 years ago
1.1K views
Shared 2 years ago
54K views
Shared 2 years ago
3.7K views
Shared 2 years ago
2.7K views
Shared 3 years ago
1.8K views
Shared 3 years ago
4.3K views
Shared 3 years ago
655 views
Shared 3 years ago
940 views
Shared 3 years ago
2.5K views